ATE456575T1 - Immun-interaktive fragmente der alpha-c- untereinheit von inhibin - Google Patents

Immun-interaktive fragmente der alpha-c- untereinheit von inhibin

Info

Publication number: ATE456575T1
Authority: AT; Austria
Prior art keywords: inhibin; subunit; interactive; immune; alpha
Prior art date: 1999-10-18

Application number

AT00971123T

Other languages

English (en)

Inventor

Nicholas Cahir

David Milne-Robertson

Peter Stanton

Original Assignee

Prince Henrys Inst Med Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-18

Filing date

2000-10-18

Publication date

2010-02-15

1999-10-18 Priority claimed from AUPQ3485A external-priority patent/AUPQ348599A0/en

2000-08-03 Priority claimed from AUPQ9162A external-priority patent/AUPQ916200A0/en

2000-10-18 Application filed by Prince Henrys Inst Med Res filed Critical Prince Henrys Inst Med Res

2010-02-15 Application granted granted Critical

2010-02-15 Publication of ATE456575T1 publication Critical patent/ATE456575T1/de

Links

239000000893 inhibin Substances 0.000 title abstract 4
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title abstract 4
239000012634 fragment Substances 0.000 title abstract 2
239000000427 antigen Substances 0.000 abstract 2
102000036639 antigens Human genes 0.000 abstract 2
108091007433 antigens Proteins 0.000 abstract 2
230000001594 aberrant effect Effects 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/811—Test for named disease, body condition or organ function
- Y10S436/813—Cancer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/85—Reproductive organs or embryos

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Biochemistry (AREA)
Endocrinology (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Oncology (AREA)
Hospice & Palliative Care (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Peptides Or Proteins (AREA)

AT00971123T 1999-10-18 2000-10-18 Immun-interaktive fragmente der alpha-c- untereinheit von inhibin ATE456575T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPQ3485A AUPQ348599A0 (en)	1999-10-18	1999-10-18	Novel peptides for development of diagnostic and therapeutic agents and methods of using same
AUPQ9162A AUPQ916200A0 (en)	2000-08-03	2000-08-03	Novel peptides for development of diagnostic and therapeutic agents and methods of using same
PCT/AU2000/001258 WO2001029079A1 (en)	1999-10-18	2000-10-18	IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN

Publications (1)

Publication Number	Publication Date
ATE456575T1 true ATE456575T1 (de)	2010-02-15

Family

ID=25646178

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00971123T ATE456575T1 (de)	1999-10-18	2000-10-18	Immun-interaktive fragmente der alpha-c- untereinheit von inhibin

Country Status (8)

Country	Link
US (2)	US7511123B2 (de)
EP (2)	EP1226166B1 (de)
AT (1)	ATE456575T1 (de)
CA (2)	CA2387576C (de)
DE (1)	DE60043782D1 (de)
DK (1)	DK1226166T3 (de)
NZ (1)	NZ518320A (de)
WO (1)	WO2001029079A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004223796A1 (en) *	2003-03-28	2004-10-07	Monash University	Diagnosis of advanced cancer
GB2594002B (en) *	2016-06-24	2022-04-13	Univ South Carolina	Inhibin as targetable regulators of angiogenesis
CN116253790A (zh) *	2022-12-13	2023-06-13	迪亚莱博（张家港）生物科技有限公司	一种用于抗nmdar抗体检测的nmdar重组蛋白及其制备方法及其应用
CN116375844B (zh) *	2023-02-22	2024-03-29	四川农业大学	一种抑制素抗原肽及其疫苗和制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4018653A (en)	1971-10-29	1977-04-19	U.S. Packaging Corporation	Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en)	1975-09-04	1977-04-05	Akzona Incorporated	Enzymatic immunological method for the determination of antigens and antibodies
US4843000A (en)	1979-12-26	1989-06-27	Syntex (U.S.A.) Inc.	Simultaneous calibration heterogeneous immunoassay
US4849338A (en)	1982-07-16	1989-07-18	Syntex (U.S.A.) Inc.	Simultaneous calibration heterogeneous immunoassay
US4366241A (en)	1980-08-07	1982-12-28	Syva Company	Concentrating zone method in heterogeneous immunoassays
US4424279A (en)	1982-08-12	1984-01-03	Quidel	Rapid plunger immunoassay method and apparatus
AU4437485A (en)	1984-06-08	1986-01-10	Biotechnology Australia Proprietary Limited	Inhibin isolated from ovarian follicular fluid
AU610821B2 (en)	1985-04-18	1991-05-30	Inhibin Pty Limited	Recombinant inhibin
US4737578A (en) *	1986-02-10	1988-04-12	The Salk Institute For Biological Studies	Human inhibin
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US4946778A (en)	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
WO1988005789A1 (en)	1987-01-29	1988-08-11	Biotechnology Australia Pty. Ltd.	Isolation of single chain proteins with fsh suppressing activity from follicular fluid
US5091513A (en)	1987-05-21	1992-02-25	Creative Biomolecules, Inc.	Biosynthetic antibody binding sites
US5785973A (en)	1988-02-01	1998-07-28	Praxis Biologics, Inc.	Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines
US5223409A (en)	1988-09-02	1993-06-29	Protein Engineering Corp.	Directed evolution of novel binding proteins
US5274113A (en)	1991-11-01	1993-12-28	Molecular Probes, Inc.	Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates
US5433896A (en)	1994-05-20	1995-07-18	Molecular Probes, Inc.	Dibenzopyrrometheneboron difluoride dyes
US5648270A (en)	1995-02-06	1997-07-15	Molecular Probes, Inc.	Methods of sensing with fluorescent conjugates of metal-chelating nitrogen heterocycles
US5326692B1 (en)	1992-05-13	1996-04-30	Molecular Probes Inc	Fluorescent microparticles with controllable enhanced stokes shift
US5453517A (en)	1992-02-25	1995-09-26	Molecular Probes, Inc.	Reactive derivatives of bapta used to make ion-selective chelators
US5227487A (en)	1990-04-16	1993-07-13	Molecular Probes, Inc.	Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5405975A (en)	1993-03-29	1995-04-11	Molecular Probes, Inc.	Fluorescent ion-selective diaryldiaza crown ether conjugates
US5459276A (en)	1994-05-20	1995-10-17	Molecular Probes, Inc.	Benzazolylcoumarin-based ion indicators for heavy metals
US5723218A (en)	1990-04-16	1998-03-03	Molecular Probes, Inc.	Dipyrrometheneboron difluoride labeled flourescent microparticles
CA2087256A1 (en)	1990-07-25	1992-01-26	Jerry L. Ruth	Circular extension for generating multiple nucleic acid complements
JP2001524926A (ja)	1991-09-18	2001-12-04	アフィマックステクノロジーズナームロゼフェンノートシャップ	オリゴマーの雑多ライブラリーの集合体を合成する方法
CA2126967A1 (en)	1992-11-04	1994-05-11	Anna M. Wu	Novel antibody construct
EP0628078B1 (de)	1992-12-11	1999-12-08	The Dow Chemical Company	Multivalente einkettige Antikörper
US5422252A (en)	1993-06-04	1995-06-06	Becton, Dickinson And Company	Simultaneous amplification of multiple targets
GB9410345D0 (en) *	1994-05-24	1994-07-13	Univ Oxford Brookes	Method of genetic testing
AU714486B2 (en)	1995-11-21	2000-01-06	Yale University	Unimolecular segment amplification and detection
US5990085A (en) *	1998-05-04	1999-11-23	Michigan State University	Inhibin-HBc fusion protein

2000
- 2000-10-18 DK DK00971123.5T patent/DK1226166T3/da active
- 2000-10-18 NZ NZ518320A patent/NZ518320A/en not_active IP Right Cessation
- 2000-10-18 CA CA2387576A patent/CA2387576C/en not_active Expired - Fee Related
- 2000-10-18 WO PCT/AU2000/001258 patent/WO2001029079A1/en active IP Right Grant
- 2000-10-18 EP EP00971123A patent/EP1226166B1/de not_active Expired - Lifetime
- 2000-10-18 DE DE60043782T patent/DE60043782D1/de not_active Expired - Lifetime
- 2000-10-18 AT AT00971123T patent/ATE456575T1/de not_active IP Right Cessation
- 2000-10-18 EP EP09004549A patent/EP2112159A3/de not_active Withdrawn
- 2000-10-18 CA CA2642066A patent/CA2642066C/en not_active Expired - Fee Related
2002
- 2002-04-18 US US10/125,187 patent/US7511123B2/en not_active Expired - Fee Related
2009
- 2009-03-30 US US12/414,180 patent/US8399202B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US8399202B2 (en)	2013-03-19
DE60043782D1 (de)	2010-03-18
US20030162229A1 (en)	2003-08-28
CA2642066C (en)	2010-01-26
NZ518320A (en)	2003-10-31
EP2112159A3 (de)	2010-04-21
US20090252735A1 (en)	2009-10-08
EP1226166B1 (de)	2010-01-27
CA2387576A1 (en)	2001-04-26
WO2001029079A1 (en)	2001-04-26
EP2112159A2 (de)	2009-10-28
US7511123B2 (en)	2009-03-31
EP1226166A1 (de)	2002-07-31
CA2642066A1 (en)	2001-04-26
DK1226166T3 (da)	2010-05-25
EP1226166A4 (de)	2004-09-22
CA2387576C (en)	2011-05-10

Publication	Publication Date	Title
NO983284L (no)	1998-09-16	Anvendelse av et anti-faktor 1X monoklonalt antistoff og en nukleinsyre som koder for et monoklonalt antistoff for fremstilling av et medikament for behandling av trombose- og emboli-assosierte lidelser.
ATE234092T1 (de)	2003-03-15	2-alkylpyrrolidine
ATE470676T1 (de)	2010-06-15	Anti-vegf-2 antikörper
NO20032036L (no)	2003-07-04	Kombinasjoner av medikamenter (f.eks. klorpromazin og pentamidiner) for behandling av neoplastiske forstyrrelser
DE60231295D1 (de)	2009-04-09	R und ppar modulatoren
CY1110894T1 (el)	2015-06-10	Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης
ATE551362T1 (de)	2012-04-15	Peptide, die den blutzuckergehalt senken
DK1459750T3 (da)	2005-08-15	(S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
BR0000695A (pt)	2000-08-22	Processo e aparelho para a lavagem e a hidratação de dispositivos oftálmicos
CY1112229T1 (el)	2015-12-09	Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
PT1224205E (pt)	2006-08-31	Derivados 5-beta-sapogenina e pseudo-sapogenina e sua utilizacao no tratamento de demencia
NO965319D0 (no)	1996-12-12	Rutil titandioksyd, og fremgangsmåte for fremstilling derav
DE602004021847D1 (de)	2009-08-13	Verfahren zur prävention und behandlung von diabetes mit neurturin
DK1220852T3 (da)	2006-05-15	Substituerede diazepaner
ATE456575T1 (de)	2010-02-15	Immun-interaktive fragmente der alpha-c- untereinheit von inhibin
DE69205873D1 (de)	1995-12-14	Verfahren zur Produktion von Ethylen-alpha-olefincopolymeren.
DE59003798D1 (de)	1994-01-20	Verfahren zur Herstellung von gesättigten, fluorhaltigen und chlorfreien Kohlenwasserstoffen.
FR2707994B1 (fr)	1995-09-15	Composites moléculaires de siloxane, procédé de préparation desdits composites, et leurs utilisations.
ATE400560T1 (de)	2008-07-15	Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
ITGE940100A0 (it)	1994-09-07	Procedimento e dispositivo per la produzione di un filo ritorto.
WO2003038130A8 (en)	2004-04-22	Therapeutics and diagnostics for disorders of erythropoiesis
NO20012423D0 (no)	2001-05-16	Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser
BR9813465A (pt)	2002-01-22	Polissacarìdeos modificados que exibem reconhecimento biológico alterado
ITRM930502A0 (it)	1993-07-29	Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
ES2061007T3 (es)	1994-12-01	Preparacion farmaceutica que contiene proteina-s.

Legal Events

Date	Code	Title	Description
2010-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties